Paroxetine Extended-Release Tablets

Paroxetine Extended-Release Tablets
Product Description

For the treatment of Major Depressive Disorder (MDD), Panic Disorder (PD), Social Anxiety Disorder (SAD) and Premenstrual Dysphoric Disorder (PMDD).

Visum Pharmaceutical

  • CN
  • 2022
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)

Visum Pharmaceutical

  • CN
  • 2022
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)

More Products from Visum Pharmaceutical (6)

  • Analytical Method Develpment and Validation

    Product Analytical Method Develpment and Validation

    Providing Analytical method development, validation and stability study from Phase I-III to commercial prodcution and registration.
  • CDMO- Generics/OTCs in Tablets, Capsules, Granules...

    Product CDMO- Generics/OTCs in Tablets, Capsules, Granules...

    FDA approved facility in China providing Contract Development and Manufacturing Services in Various Dosage Forms: • Tablets • Capsules • Granules/Powder for OS • Oral Solutions • Drops • Ointment • Cream • Gel

    Applicable for most generics/OTCs and innovative drugs.
  • Clinical Supply Manufacturing

    Product Clinical Supply Manufacturing

    NCEs • Phase I-III formulation process development and clinical supply manufacturing Generic drugs
    • BE sample manufacturing • Process Optimization
  • Commercial Manufacturing (CMO)

    Product Commercial Manufacturing (CMO)

    Standards: • US, EU, China, WHO Commercial Scales
    • Tablets: 3 billion/year • Capsules: 500 million/year • Oral solution: 100 million/year • Ointment: 50 million/year • Granules: 300 million/year
  • Formulation Development

    Product Formulation Development

    NCEs • Phase I-III formulation and development Generic Drugs • Pharmaceutical, analytical method development and process study
  • Metoprolol Succinate Extended-Release Tablets

    Product Metoprolol Succinate Extended-Release Tablets

    Metoprolol Succinate Extended-Release Tablets is a beta 1-selevitve adrenoceptor blocking agent, which can  reduce heart rate, myocardial contractility, blood pressure, antagonize the toxicity of catecholamine adreneric transmitters, and has good cardiovascular protection. It is widely used in cardiov...